Sandilya edits Hormone Journal — independent, evidence-led coverage with verifiable sourcing and a transparent methodology.
Recent articles
- NewsPCOS renamed to PMOS: what the global nomenclature shift means for Canadian patients and clinicians6 min read
- NewsPCOS renamed to PMOS: what the global nomenclature shift means for Canadian patients6 min read
- NewsHealth Canada approves first generic semaglutide injection for weight loss: what it means for Canadian patients6 min read
- NewsNew study links GLP-1 drugs to smell and taste loss: what Canadian weight-loss patients should know6 min read
- NewsNew study: Canadian women on hormone therapy show healthier diet, activity, and sleep patterns6 min read
- NewsNEJM updates thyroid cancer management: what Canadian endocrinologists and patients need to know6 min read
- NewsGLP-1 weight-loss drugs may boost testosterone and sperm count in men, new research suggests6 min read
- NewsNew study: surgical menopause linked to more severe genitourinary symptoms — what Canadian patients should know6 min read
- NewsAstraZeneca's oral GLP-1 pill shows weight-loss results comparable to Ozempic and Wegovy — what does it mean for Canadian access?6 min read
- NewsAstraZeneca's oral GLP-1 pill shows weight-loss promise: what Canadian patients need to know5 min read
- NewsOsteoporosis Canada warns GLP-1 users about bone-health risks: what Canadian patients need to know6 min read
- NewsStudy links endometriosis and infertility to early menopause risk: what Canadian patients should know7 min read
- NewsGLP-1 'microdosing' for weight loss lacks evidence—what Canadian patients should know6 min read
- LaunchesFelix Health launches generic semaglutide across Canada: what it means for GLP-1 access and cost6 min read